Blood plasma and tumor tissue were collected from the surgical mice at the study endpoint to assess whether tumor formation could lead to a reduction in plasma levels of AZGP1 and/or alter the expression of specific proteins. The gene discussed is AZGP1; the disease is neoplasm.